MMA Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Hold
2,502
0.13% 141
2026
Q1
$320K Buy
+2,502
New +$312K 0.11% 155
2025
Q4
Sell
-587
Closed -$58.8K 308
2025
Q3
$58.8K Buy
+587
New +$52.9K 0.02% 199
2024
Q2
Sell
-87
Closed -$8.21K 249
2024
Q1
$8.21K Buy
+87
New +$8.07K ﹤0.01% 202
2021
Q1
Sell
-1,518
Closed -$214K 97
2020
Q4
$214K Buy
+1,518
New +$194K 0.21% 85

Other funds holding XBI

MMA Asset Management's XBI Position: Q2 2026 in Review

MMA Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,502 shares worth $396K. The position accounts for 0.13% of the portfolio, ranked #141.

MMA Asset Management first reported a position in XBI in Q4 2020 and has held it in 5 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • MMA Asset Management held 2,502 shares of State Street SPDR S&P Biotech ETF worth $396K as of Q2 2026.
  • MMA Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.13% of MMA Asset Management's portfolio in Q2 2026, its #141 holding.
  • MMA Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 5 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on MMA Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.